Pterocarpus and Regulated Blood miRNA Expression

Doses used in studies

mg/day: 10–100 (median 55, IQR 10–100) — 1 study

Time to effect

Median: 2.8 months · IQR 2.8 months–2.8 months · Range 2.8 months–2.8 months — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityReported
No adverse events were reported during the trial in any participant, and no abnormalities were observed upon examination by the responsible physician.
from: Analysis of the Effects of Short-Term Pterostilbene Intake on Healthy Participants: A Pilo

1 of 1 paper

Analysis of the Effects of Short-Term Pterostilbene Intake on Healthy Participants: A Pilot Study.

2025-01-01
RCT
Journal of nutritional science and vitaminology 71(1)
- Kurataka Otsuka
- Daisuke Kuriki
- Keiko Kamachi
- Akira Tanaka
- Ryosuke Matsuoka

PubMed: 40024751
DOI: 10.3177/jnsv.71.70

2 Insights on

Regulated Blood miRNA Expression

High evidence
Adults

In the analysis of blood miRNA expression levels, miR-34a and miR-193b showed very high increases at week 4 and after week 4 of intake, respectively, suggesting that the responders might be present among participants in the pterostilbene intake group.

Effect: Beneficial
Effect size: Small
Significant: Yes
Dose: 10 or 100 mg/d over 12 wk